Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that it has entered ...
Roku's balance sheet holds no debt, and more than 20% of its market cap is made up of cash. Check out why I find myself cautiously neutral on ROKU stock.
our anticipated use of cash; and the strength of our balance sheet. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "expects," "plans," "anticipates, ...
Perdoceo Education Corporation (NASDAQ: PRDO) today reported operating and financial results for the quarter and year to date ended September 30, 2024. Third Quarter 2024 Results as Compared to Prior ...